Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

STAP-2 positively regulates FcRI-mediated basophil activation and basophil-dependent allergic inflammatory reaction.

Kashiwakura JI, Yamashita S, Yoshihara M, Inui K, Saitoh K, Sekine Y, Muromoto R, Kitai Y, Oritani K, Matsuda T.

Int Immunol. 2019 Feb 6. doi: 10.1093/intimm/dxz013. [Epub ahead of print]

PMID:
30726917
2.

Variable SATB1 Levels Regulate Hematopoietic Stem Cell Heterogeneity with Distinct Lineage Fate.

Doi Y, Yokota T, Satoh Y, Okuzaki D, Tokunaga M, Ishibashi T, Sudo T, Ueda T, Shingai Y, Ichii M, Tanimura A, Ezoe S, Shibayama H, Kohwi-Shigematsu T, Takeda J, Oritani K, Kanakura Y.

Cell Rep. 2018 Jun 12;23(11):3223-3235. doi: 10.1016/j.celrep.2018.05.042.

3.

Thiol-Catalyzed Radical Decyanation of Aliphatic Nitriles with Sodium Borohydride.

Kawamoto T, Oritani K, Curran DP, Kamimura A.

Org Lett. 2018 Apr 6;20(7):2084-2087. doi: 10.1021/acs.orglett.8b00626. Epub 2018 Mar 8.

PMID:
29517914
4.

Identification of MS4A3 as a reliable marker for early myeloid differentiation in human hematopoiesis.

Ishibashi T, Yokota T, Satoh Y, Ichii M, Sudo T, Doi Y, Ueda T, Nagate Y, Hamanaka Y, Tanimura A, Ezoe S, Shibayama H, Oritani K, Kanakura Y.

Biochem Biophys Res Commun. 2018 Jan 15;495(3):2338-2343. doi: 10.1016/j.bbrc.2017.12.117. Epub 2017 Dec 22.

PMID:
29274779
5.

Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis.

Oritani K, Ohishi K, Okamoto S, Kirito K, Komatsu N, Tauchi T, Handa H, Saito S, Takenaka K, Shimoda K, Okada H, Amagasaki T, Wakase S, Shimozuma K, Akashi K.

Curr Med Res Opin. 2018 Mar;34(3):531-537. doi: 10.1080/03007995.2017.1415874. Epub 2018 Jan 4.

PMID:
29224367
6.

Evaluation of the dose and efficacy of ruxolitinib in Japanese patients with myelofibrosis.

Kirito K, Okamoto S, Ohishi K, Tauchi T, Handa H, Saito S, Takenaka K, Shimoda K, Oritani K, Akashi K, Okada H, Amagasaki T, Suzuki K, Yonezu T, Komatsu N.

Int J Hematol. 2018 Jan;107(1):92-97. doi: 10.1007/s12185-017-2332-z. Epub 2017 Oct 6.

PMID:
28986762
7.

STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization.

Kitai Y, Iwakami M, Saitoh K, Togi S, Isayama S, Sekine Y, Muromoto R, Kashiwakura JI, Yoshimura A, Oritani K, Matsuda T.

J Biol Chem. 2017 Nov 24;292(47):19392-19399. doi: 10.1074/jbc.M117.802884. Epub 2017 Oct 6.

8.

A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study).

Kobayashi T, Nannya Y, Ichikawa M, Oritani K, Kanakura Y, Tomita A, Kiyoi H, Kobune M, Kato J, Kawabata H, Shindo M, Torimoto Y, Yonemura Y, Hanaoka N, Nakakuma H, Hasegawa D, Manabe A, Fujishima N, Fujii N, Tanimoto M, Morita Y, Matsuda A, Fujieda A, Katayama N, Ohashi H, Nagai H, Terada Y, Hino M, Sato K, Obara N, Chiba S, Usuki K, Ohta M, Imataki O, Uemura M, Takaku T, Komatsu N, Kitanaka A, Shimoda K, Watanabe K, Tohyama K, Takaori-Kondo A, Harigae H, Arai S, Miyazaki Y, Ozawa K, Kurokawa M; for National Research Group on Idiopathic Bone Marrow Failure Syndromes.

Am J Hematol. 2017 Dec;92(12):1324-1332. doi: 10.1002/ajh.24905. Epub 2017 Sep 28.

9.

Molecular targeting of inosine-5'-monophosphate dehydrogenase by FF-10501 promotes erythropoiesis via ROS/MAPK pathway.

Ichii M, Oritani K, Murase M, Komatsu K, Yamazaki M, Kyoden R, Kito N, Nozaki Y, Saito M, Iwamura H, Kanakura Y.

Leuk Lymphoma. 2018 Feb;59(2):448-459. doi: 10.1080/10428194.2017.1339878. Epub 2017 Jul 21.

PMID:
28730859
10.

STAP-2 interacts with Pyk2 and enhances Pyk2 activity in T-cells.

Saitoh K, Tsuchiya T, Kashiwakura JI, Muromoto R, Kitai Y, Sekine Y, Oritani K, Matsuda T.

Biochem Biophys Res Commun. 2017 Jun 17;488(1):81-87. doi: 10.1016/j.bbrc.2017.05.010. Epub 2017 May 3.

11.

Autoimmune bullous disease and Hashimoto's disease complicated by acquired hemophilia A.

Nishiura N, Ujimoto D, Fujita J, Maeda T, Nakagawa Y, Kashiwagi H, Oritani K, Tomiyama Y, Kanakura Y.

Rinsho Ketsueki. 2017;58(3):233-238. doi: 10.11406/rinketsu.58.233. Review. Japanese.

PMID:
28381691
12.

Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell lymphoma with the MYD88L265P mutation.

Kida T, Tanimura A, Ono A, Matsui T, Honma K, Fujita J, Maeda T, Shibayama H, Oritani K, Morii E, Kanakura Y.

Rinsho Ketsueki. 2017;58(2):155-160. doi: 10.11406/rinketsu.58.155. Japanese.

PMID:
28321094
13.

New variant of acute promyelocytic leukemia with IRF2BP2-RARA fusion.

Shimomura Y, Mitsui H, Yamashita Y, Kamae T, Kanai A, Matsui H, Ishibashi T, Tanimura A, Shibayama H, Oritani K, Kuyama J, Kanakura Y.

Cancer Sci. 2016 Aug;107(8):1165-8. doi: 10.1111/cas.12970.

14.

Endothelial Cell-Selective Adhesion Molecule Expression in Hematopoietic Stem/Progenitor Cells Is Essential for Erythropoiesis Recovery after Bone Marrow Injury.

Sudo T, Yokota T, Okuzaki D, Ueda T, Ichii M, Ishibashi T, Isono T, Habuchi Y, Oritani K, Kanakura Y.

PLoS One. 2016 Apr 25;11(4):e0154189. doi: 10.1371/journal.pone.0154189. eCollection 2016.

15.

A New STAT3-binding Partner, ARL3, Enhances the Phosphorylation and Nuclear Accumulation of STAT3.

Togi S, Muromoto R, Hirashima K, Kitai Y, Okayama T, Ikeda O, Matsumoto N, Kon S, Sekine Y, Oritani K, Matsuda T.

J Biol Chem. 2016 May 20;291(21):11161-71. doi: 10.1074/jbc.M116.724849. Epub 2016 Apr 5.

16.

Caspase-dependent cleavage regulates protein levels of Epstein-Barr virus-derived latent membrane protein 1.

Togi S, Hatano Y, Muromoto R, Kawanishi E, Ikeda O, Hirashima K, Kon S, Kitai Y, Yasui T, Oritani K, Matsuda T.

FEBS Lett. 2016 Mar;590(6):808-18. doi: 10.1002/1873-3468.12119. Epub 2016 Mar 4.

17.

ESAM is a novel human hematopoietic stem cell marker associated with a subset of human leukemias.

Ishibashi T, Yokota T, Tanaka H, Ichii M, Sudo T, Satoh Y, Doi Y, Ueda T, Tanimura A, Hamanaka Y, Ezoe S, Shibayama H, Oritani K, Kanakura Y.

Exp Hematol. 2016 Apr;44(4):269-81.e1. doi: 10.1016/j.exphem.2015.12.010. Epub 2016 Jan 14.

PMID:
26774386
18.

[Diffuse large B-cell lymphoma occurring in a Waldenström macroglobulinemia patient with central nervous system infiltration].

Hayashi Y, Sata H, Akuta K, Toda J, Kusakabe S, Ueda T, Ueda Y, Fujita J, Tadokoro S, Maeda T, Nishimura J, Shibayama H, Oritani K, Kanakura Y.

Rinsho Ketsueki. 2015 Nov;56(11):2351-6. doi: 10.11406/rinketsu.56.2351. Japanese.

PMID:
26666724
19.

Signal transducer and activator of transcription 3 regulation by novel binding partners.

Matsuda T, Muromoto R, Sekine Y, Togi S, Kitai Y, Kon S, Oritani K.

World J Biol Chem. 2015 Nov 26;6(4):324-32. doi: 10.4331/wjbc.v6.i4.324. Review.

20.

Identification of osteoblast stimulating factor 5 as a negative regulator in the B-lymphopoietic niche.

Fujita N, Ichii M, Maeda T, Saitoh N, Yokota T, Yamawaki K, Kakitani M, Tomizuka K, Oritani K, Kanakura Y.

Exp Hematol. 2015 Nov;43(11):963-973.e4. doi: 10.1016/j.exphem.2015.07.002. Epub 2015 Jul 23.

PMID:
26213229
21.

CCR7 is involved in BCR-ABL/STAP-2-mediated cell growth in hematopoietic Ba/F3 cells.

Kubo K, Iwakami M, Muromoto R, Inagaki T, Kitai Y, Kon S, Sekine Y, Oritani K, Matsuda T.

Biochem Biophys Res Commun. 2015 Aug 7;463(4):825-31. doi: 10.1016/j.bbrc.2015.06.020. Epub 2015 Jun 21.

22.

Kaposi's sarcoma-associated herpesvirus-encoded LANA associates with glucocorticoid receptor and enhances its transcriptional activities.

Togi S, Nakasuji M, Muromoto R, Ikeda O, Okabe K, Kitai Y, Kon S, Oritani K, Matsuda T.

Biochem Biophys Res Commun. 2015 Jul 31;463(3):395-400. doi: 10.1016/j.bbrc.2015.05.080. Epub 2015 May 29.

23.

STAP-2 Protein Expression in B16F10 Melanoma Cells Positively Regulates Protein Levels of Tyrosinase, Which Determines Organs to Infiltrate in the Body.

Sekine Y, Togi S, Muromoto R, Kon S, Kitai Y, Yoshimura A, Oritani K, Matsuda T.

J Biol Chem. 2015 Jul 10;290(28):17462-73. doi: 10.1074/jbc.M115.658575. Epub 2015 May 28.

24.

PML suppresses IL-6-induced STAT3 activation by interfering with STAT3 and HDAC3 interaction.

Kato M, Muromoto R, Togi S, Iwakami M, Kitai Y, Kon S, Oritani K, Matsuda T.

Biochem Biophys Res Commun. 2015 May 29;461(2):366-71. doi: 10.1016/j.bbrc.2015.04.040. Epub 2015 Apr 17.

25.

Novel CD9-targeted therapies in gastric cancer.

Murayama Y, Oritani K, Tsutsui S.

World J Gastroenterol. 2015 Mar 21;21(11):3206-13. doi: 10.3748/wjg.v21.i11.3206. Review.

26.

Estrogen-inducible sFRP5 inhibits early B-lymphopoiesis in vivo, but not during pregnancy.

Yokota T, Oritani K, Sudo T, Ishibashi T, Doi Y, Habuchi Y, Ichii M, Fukushima K, Okuzaki D, Tomizuka K, Yamawaki K, Kakitani M, Shimono A, Morii E, Kincade PW, Kanakura Y.

Eur J Immunol. 2015 May;45(5):1390-401. doi: 10.1002/eji.201444939. Epub 2015 Mar 16.

27.

A multinational, open-label, phase 2 study of ruxolitinib in Asian patients with myelofibrosis: Japanese subset analysis.

Oritani K, Okamoto S, Tauchi T, Saito S, Ohishi K, Handa H, Takenaka K, Gopalakrishna P, Amagasaki T, Ito K, Akashi K.

Int J Hematol. 2015 Mar;101(3):295-304. doi: 10.1007/s12185-015-1746-8. Epub 2015 Feb 1.

PMID:
25638222
28.

Quantitative polymerase chain reaction analysis with allele-specific oligonucleotide primers for individual IgH VDJ regions to evaluate tumor burden in myeloma patients.

Sata H, Shibayama H, Maeda I, Habuchi Y, Nakatani E, Fukushima K, Fujita J, Ezoe S, Tadokoro S, Maeda T, Mizuki M, Kosugi S, Nakagawa M, Ueda S, Iida M, Tokumine Y, Azenishi Y, Mitsui H, Oritani K, Kanakura Y.

Exp Hematol. 2015 May;43(5):374-381.e2. doi: 10.1016/j.exphem.2015.01.002. Epub 2015 Jan 13.

PMID:
25591497
29.

Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis.

Jung CW, Shih LY, Xiao Z, Jie J, Hou HA, Du X, Wang MC, Park S, Eom KS, Oritani K, Okamoto S, Tauchi T, Kim JS, Zhou D, Saito S, Li J, Handa H, Jianyong L, Ohishi K, Hou M, Depei W, Takenaka K, Liu T, Hu Y, Amagasaki T, Ito K, Gopalakrishna P, Akashi K.

Leuk Lymphoma. 2015 Jul;56(7):2067-74. doi: 10.3109/10428194.2014.969260. Epub 2014 Nov 20.

PMID:
25315076
30.

Clathrin assembly protein CALM plays a critical role in KIT signaling by regulating its cellular transport from early to late endosomes in hematopoietic cells.

Rai S, Tanaka H, Suzuki M, Ogoh H, Taniguchi Y, Morita Y, Shimada T, Tanimura A, Matsui K, Yokota T, Oritani K, Tanabe K, Watanabe T, Kanakura Y, Matsumura I.

PLoS One. 2014 Oct 3;9(10):e109441. doi: 10.1371/journal.pone.0109441. eCollection 2014.

31.

Early B lymphocyte development: Similarities and differences in human and mouse.

Ichii M, Oritani K, Kanakura Y.

World J Stem Cells. 2014 Sep 26;6(4):421-31. doi: 10.4252/wjsc.v6.i4.421. Review.

32.

Signal-transducing adaptor protein-2 regulates macrophage migration into inflammatory sites during dextran sodium sulfate induced colitis.

Fujita N, Oritani K, Ichii M, Yokota T, Saitoh N, Okuzaki D, Sekine Y, Kon S, Muromoto R, Saitoh K, Yoshimura A, Matsuda T, Kanakura Y.

Eur J Immunol. 2014 Jun;44(6):1791-801. doi: 10.1002/eji.201344239. Epub 2014 Apr 15.

33.

Signal-transducing adaptor protein-2 controls the IgE-mediated, mast cell-mediated anaphylactic responses.

Sekine Y, Nishida K, Yamasaki S, Muromoto R, Kon S, Kashiwakura J, Saitoh K, Togi S, Yoshimura A, Oritani K, Matsuda T.

J Immunol. 2014 Apr 15;192(8):3488-95. doi: 10.4049/jimmunol.1300886. Epub 2014 Mar 10.

34.

The anti-apoptotic gene Anamorsin is essential for both autonomous and extrinsic regulation of murine fetal liver hematopoiesis.

Tanimura A, Shibayama H, Hamanaka Y, Fujita N, Ishibashi T, Sudo T, Yokota T, Ezoe S, Tanaka H, Matsumura I, Oritani K, Kanakura Y.

Exp Hematol. 2014 May;42(5):410-422.e4. doi: 10.1016/j.exphem.2014.01.002. Epub 2014 Jan 16.

PMID:
24440520
35.

Tyk2 is a therapeutic target for psoriasis-like skin inflammation.

Ishizaki M, Muromoto R, Akimoto T, Sekine Y, Kon S, Diwan M, Maeda H, Togi S, Shimoda K, Oritani K, Matsuda T.

Int Immunol. 2014 May;26(5):257-67. doi: 10.1093/intimm/dxt062. Epub 2013 Dec 17.

36.

Jun activation domain-binding protein 1 (JAB1) is required for the optimal response to interferons.

Muromoto R, Nakajima M, Hirashima K, Hirao T, Kon S, Shimoda K, Oritani K, Matsuda T.

J Biol Chem. 2013 Oct 25;288(43):30969-79. doi: 10.1074/jbc.M113.485847. Epub 2013 Sep 16.

37.

Y14 positively regulates TNF-α-induced NF-κB transcriptional activity via interacting RIP1 and TRADD beyond an exon junction complex protein.

Togi S, Shiga K, Muromoto R, Kato M, Souma Y, Sekine Y, Kon S, Oritani K, Matsuda T.

J Immunol. 2013 Aug 1;191(3):1436-44. doi: 10.4049/jimmunol.1300501. Epub 2013 Jul 1.

38.

The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages.

Satoh Y, Yokota T, Sudo T, Kondo M, Lai A, Kincade PW, Kouro T, Iida R, Kokame K, Miyata T, Habuchi Y, Matsui K, Tanaka H, Matsumura I, Oritani K, Kohwi-Shigematsu T, Kanakura Y.

Immunity. 2013 Jun 27;38(6):1105-15. doi: 10.1016/j.immuni.2013.05.014. Epub 2013 Jun 20.

39.

[Cell surface markers].

Oritani K.

Nihon Rinsho. 2012 Apr;70 Suppl 2:171-5. Japanese. No abstract available.

PMID:
23133947
40.

[Development and differentiation systems of lymphocyte].

Oritani K.

Rinsho Ketsueki. 2012 Oct;53(10):1838-48. Review. Japanese. No abstract available.

PMID:
23037759
41.

The endothelial antigen ESAM monitors hematopoietic stem cell status between quiescence and self-renewal.

Sudo T, Yokota T, Oritani K, Satoh Y, Sugiyama T, Ishida T, Shibayama H, Ezoe S, Fujita N, Tanaka H, Maeda T, Nagasawa T, Kanakura Y.

J Immunol. 2012 Jul 1;189(1):200-10. doi: 10.4049/jimmunol.1200056. Epub 2012 May 30.

42.

Signal-transducing adaptor protein-2 modulates Fas-mediated T cell apoptosis by interacting with caspase-8.

Sekine Y, Yamamoto C, Kakisaka M, Muromoto R, Kon S, Ashitomi D, Fujita N, Yoshimura A, Oritani K, Matsuda T.

J Immunol. 2012 Jun 15;188(12):6194-204. doi: 10.4049/jimmunol.1103467. Epub 2012 May 18.

43.

Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study.

Usuki K, Tojo A, Maeda Y, Kobayashi Y, Matsuda A, Ohyashiki K, Nakaseko C, Kawaguchi T, Tanaka H, Miyamura K, Miyazaki Y, Okamoto S, Oritani K, Okada M, Usui N, Nagai T, Amagasaki T, Wanajo A, Naoe T.

Int J Hematol. 2012 Apr;95(4):409-19. doi: 10.1007/s12185-012-1026-9. Epub 2012 Feb 23.

PMID:
22359103
44.

NAD-dependent histone deacetylase, SIRT1, plays essential roles in the maintenance of hematopoietic stem cells.

Matsui K, Ezoe S, Oritani K, Shibata M, Tokunaga M, Fujita N, Tanimura A, Sudo T, Tanaka H, McBurney MW, Matsumura I, Kanakura Y.

Biochem Biophys Res Commun. 2012 Feb 24;418(4):811-7. doi: 10.1016/j.bbrc.2012.01.109. Epub 2012 Jan 28.

PMID:
22306819
45.

STAP-2 interacts with and modulates BCR-ABL-mediated tumorigenesis.

Sekine Y, Ikeda O, Mizushima A, Ueno Y, Muromoto R, Yoshimura A, Kanakura Y, Oritani K, Matsuda T.

Oncogene. 2012 Oct 4;31(40):4384-96. doi: 10.1038/onc.2011.604. Epub 2012 Jan 9.

46.

Krüppel-associated box-associated protein 1 negatively regulates TNF-α-induced NF-κB transcriptional activity by influencing the interactions among STAT3, p300, and NF-κB/p65.

Kamitani S, Togi S, Ikeda O, Nakasuji M, Sakauchi A, Sekine Y, Muromoto R, Oritani K, Matsuda T.

J Immunol. 2011 Sep 1;187(5):2476-83. doi: 10.4049/jimmunol.1003243. Epub 2011 Aug 1.

47.

Tyk2 deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice.

Ishizaki M, Muromoto R, Akimoto T, Ohshiro Y, Takahashi M, Sekine Y, Maeda H, Shimoda K, Oritani K, Matsuda T.

Int Immunol. 2011 Sep;23(9):575-82. doi: 10.1093/intimm/dxr057. Epub 2011 Jul 16.

48.

Involvement of tyrosine kinase-2 in both the IL-12/Th1 and IL-23/Th17 axes in vivo.

Ishizaki M, Akimoto T, Muromoto R, Yokoyama M, Ohshiro Y, Sekine Y, Maeda H, Shimoda K, Oritani K, Matsuda T.

J Immunol. 2011 Jul 1;187(1):181-9. doi: 10.4049/jimmunol.1003244. Epub 2011 May 23.

49.

Zipper-interacting protein kinase (ZIPK) modulates canonical Wnt/beta-catenin signaling through interaction with Nemo-like kinase and T-cell factor 4 (NLK/TCF4).

Togi S, Ikeda O, Kamitani S, Nakasuji M, Sekine Y, Muromoto R, Nanbo A, Oritani K, Kawai T, Akira S, Matsuda T.

J Biol Chem. 2011 May 27;286(21):19170-7. doi: 10.1074/jbc.M110.189829. Epub 2011 Mar 30.

50.

Predictability of the response to tyrosine kinase inhibitors via in vitro analysis of Bcr-Abl phosphorylation.

Shibata M, Ezoe S, Oritani K, Matsui K, Tokunaga M, Fujita N, Saito Y, Takahashi T, Hino M, Matsumura I, Kanakura Y.

Leuk Res. 2011 Sep;35(9):1205-11. doi: 10.1016/j.leukres.2011.01.012. Epub 2011 Mar 26.

PMID:
21440936

Supplemental Content

Loading ...
Support Center